U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
111451111451Imaging Biomarkers of Progression of Mobility Impairment in Parkinson's Disease (PD)CompletedNo Results AvailableParkinson's Diseasehttps://ClinicalTrials.gov/show/NCT01106976
111452111452Anterior Knee Pain After Tibial NailingCompletedNo Results AvailableKnee PainProcedure: Tibial intramedullary nailinghttps://ClinicalTrials.gov/show/NCT01106963
111453111453Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)TerminatedHas ResultsLeukemia, Myelogenous, AcuteBiological: Natural Killer Cells|Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Denileukin diftitox|Procedure: Donor lymphapheresis|Drug: IL-2https://ClinicalTrials.gov/show/NCT01106950
111454111454Factor XIII and Pulmonary Embolism in Neurosurgical PatientsRecruitingNo Results AvailableBrain Tumor|Vascular Lesion|Factor XIII Deficiency|Pulmonary Embolismhttps://ClinicalTrials.gov/show/NCT01106937
111455111455Effects of a Probiotic on Body WeightCompletedNo Results AvailableObesityOther: Probiotic|Other: Placebohttps://ClinicalTrials.gov/show/NCT01106924
111456111456Assessment of Digital Breast Tomosynthesis (DBT) in the Screening EnvironmentRecruitingNo Results AvailableBreast AbnormalitiesDevice: tomosynthesis and screening mammographyhttps://ClinicalTrials.gov/show/NCT01106911
111457111457Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Treating Women With Stage I or Stage II Breast Cancer Who Have Undergone SurgeryRecruitingNo Results AvailableStage I Breast Cancer|Stage II Breast CancerDrug: cyclophosphamide|Drug: paclitaxel|Biological: trastuzumabhttps://ClinicalTrials.gov/show/NCT01106898
111458111458Effective Care Management of Depressed Diabetes Patients (The Positive Steps Study)CompletedNo Results AvailableDiabetes|DepressionBehavioral: Medication Care Management (MCM)|Behavioral: Cognitive-Behavioral Therapy (CBT)https://ClinicalTrials.gov/show/NCT01106885
111459111459Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasRecruitingNo Results AvailableSarcoma|Soft Tissue Sarcoma|Locally Advanced Sarcoma|Unresectable Sarcoma|Metastatic SarcomaDrug: Bevacizumab, Gemcitabine, docetaxel and valproic acidhttps://ClinicalTrials.gov/show/NCT01106872
111460111460Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual TabletCompletedHas ResultsInsomniaDrug: zopiclone|Drug: zolpidem tartrate sublingual tablet|Drug: Placebo (sublingual tablet)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01106859
111461111461Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation SurgeryTerminatedHas ResultsPainDrug: Group A: Saline Group|Drug: Group B: 1% Ketamine grouphttps://ClinicalTrials.gov/show/NCT01106846
111462111462Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)Active, not recruitingNo Results AvailableChronic GVHDDrug: Sirolimus + calcineurin inhibitor + prednisone|Drug: Sirolimus + prednisonehttps://ClinicalTrials.gov/show/NCT01106833
111463111463Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of LifeCompletedNo Results AvailableBreast Cancer|Cancer-related FatigueOther: Supervised progressive resistance training|Other: Supervised progressive muscle relaxation training (Jacobsen method)https://ClinicalTrials.gov/show/NCT01106820
111464111464Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With AcneCompletedNo Results AvailableAcneDrug: Epiduo vehicle gel|Drug: CD07223|Drug: CD07223|Drug: Epiduo (adapalene and benzoyl peroxide) 0.1%/2.5% gelhttps://ClinicalTrials.gov/show/NCT01106807
111465111465Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem GliomaRecruitingNo Results AvailableDiffuse Intrinsic Pontine Glioma|Brainstem Gliomahttps://ClinicalTrials.gov/show/NCT01106794
111466111466A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma HistologyCompletedNo Results AvailableNon-Small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01106781
111467111467Evaluation of Oral Needs of Children With Disorder Attention Deficit/Hyperactivity DisorderRecruitingNo Results AvailableAttention Deficit Disorder With Hyperactivityhttps://ClinicalTrials.gov/show/NCT01106768
111468111468Effects of Ground Level Gait Training With Body Weight Support (BWS) and Functional Electrical Stimulation (FES)CompletedNo Results AvailableHemiparesis|StrokeDevice: gait training on ground level using BWS|Device: gait training on ground level using BWS associated to FEShttps://ClinicalTrials.gov/show/NCT01106755
111469111469Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)CompletedNo Results AvailableInflammatory Bowel DiseaseDietary Supplement: AndoSanhttps://ClinicalTrials.gov/show/NCT01106742
111470111470Tracing the Path of an Ingested Plant Pigment Through the Human BodyCompletedNo Results AvailableMetabolism and Clearance of Cyanidin 3 GlucosideDietary Supplement: Cyanidin 3 glucosidehttps://ClinicalTrials.gov/show/NCT01106729
111471111471Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic NeuralgiaCompletedNo Results AvailablePostherpetic NeuralgiaDrug: Placebo|Drug: KAI-1678|Drug: Lidocainehttps://ClinicalTrials.gov/show/NCT01106716
111472111472The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE LevelsCompletedNo Results AvailableAsymptomatic Subjects With Atopy and Elevated Serum IgEDietary Supplement: PG102, a water soluble extract from Actinidia arguta|Other: placebohttps://ClinicalTrials.gov/show/NCT01106703
111473111473The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Placebo|Drug: Canagliflozin|Drug: Sitagliptin|Drug: Metformin|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT01106690
111474111474The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Placebo|Drug: Canagliflozin|Drug: Sitagliptin|Drug: Metformin immediate releasehttps://ClinicalTrials.gov/show/NCT01106677
111475111475ONO-7746 Study in Healthy Adult SubjectCompletedNo Results AvailableHealthy Adult SubjectsDrug: ONO-7746|Drug: ONO-7746https://ClinicalTrials.gov/show/NCT01106664
111476111476A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Canagliflozin 100 mg|Drug: Canagliflozin 300 mg|Drug: Antihyperglycemic agent(s)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01106651
111477111477A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)RecruitingNo Results AvailableSmoking|HIV Infections|AIDSBehavioral: Positively Smoke Free|Behavioral: Standard carehttps://ClinicalTrials.gov/show/NCT01106638
111478111478The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)CompletedHas ResultsDiabetes Mellitus, Type 2Drug: Canagliflozin|Drug: Placebo|Drug: Metformin|Drug: Sulphonylrueahttps://ClinicalTrials.gov/show/NCT01106625
111479111479Study Comparing CT Scan and Stress Test in Patients With Known Coronary Artery Disease Hospitalized for Chest PainTerminatedNo Results AvailableCoronary Artery Disease|Angina Pectoris|Unstable Angina|Acute Coronary SyndromeProcedure: Coronary CT angiography|Procedure: Myocardial perfusion imaginghttps://ClinicalTrials.gov/show/NCT01106612
111480111480A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNo Results AvailableSolid CancersDrug: GDC-0623https://ClinicalTrials.gov/show/NCT01106599

* Görseller ve İçerik tekif hakkına sahip olabilir